Works matching IS 08909091 AND DT 2022 AND VI 36 AND IP 4

Results: 13

Metastatic Renal Cell Carcinoma With Sarcomatoid Features.

Published in:

Oncology (08909091), 2022, v. 36, n. 4, p. 221

By:

Mateos-Soria, Abigail;
Castro-Alonso, Francisco J.;
Şener, Yusuf Z.;
Quintero-Bustos, Gabriel;
Licano-Zubiate, Mariana;
Bourlon, Rene;
Lam, Elaine T.;
Bourlon, Maria T.

Publication type:

Article

Current Treatments in Marginal Zone Lymphoma.

Published in:

Oncology (08909091), 2022, v. 36, n. 4, p. 206

By:

Alderuccio, Juan Pablo;
Kahl, Brad S.

Publication type:

Article

Sholl Examines Importance of Pathology in Cancer Care.

Published in:

Oncology (08909091), 2022, v. 36, n. 4, p. 200

By:

Sholl, Lynette M.

Publication type:

Article

Asciminib.

Published in:: Oncology (08909091), 2022, v. 36, n. 4, p. 236
Publication type:: Article

What Do American Board of Internal Medicine Recertification Exams Measure?

Published in:

Oncology (08909091), 2022, v. 36, n. 4, p. 199

By:

Vose, Julie M.

Publication type:

Article

Correction.

Published in:: Oncology (08909091), 2022, v. 36, n. 4, p. 198
Publication type:: Article

Immunotherapy Biomarkers and New Targets in Head and Neck Cancer.

Published in:

Oncology (08909091), 2022, v. 36, n. 4, p. 251

By:

Uppaluri, Ravindra

Publication type:

Article

Choueiri Discusses Results of CLEAR Substudy of Lenvatinib Plus Pembrolizumab in RCC.

Published in:: Oncology (08909091), 2022, v. 36, n. 4, p. 250
Publication type:: Article

East Asian Patients With Advanced RCC Benefit from Lenvatinib Plus Pembrolizumab.

Published in:: Oncology (08909091), 2022, v. 36, n. 4, p. 250
Publication type:: Article

PRESIDE Meets PFS End Point With Continuous Enzalutamide After Progression of mCRPC.

Published in:: Oncology (08909091), 2022, v. 36, n. 4, p. 249
Publication type:: Article

Signifi cant OS Boost Seen With Darolutamide Plus ADT in Metastatic CSPC.

Published in:: Oncology (08909091), 2022, v. 36, n. 4, p. 249
Publication type:: Article

2022 Genitourinary Cancers Symposium 2-Minute Drill: Experts Review Most Impactful Data.

Published in:: Oncology (08909091), 2022, v. 36, n. 4, p. 242
Publication type:: Article

Addendum.

Published in:: Oncology (08909091), 2022, v. 36, n. 4, p. 198
Publication type:: Article